ExposeIQ adds JuryFit to help healthcare litigators sharpen voir dire

ExposeIQ says its JuryFit platform is helping healthcare litigation attorneys analyze juror profiles, test trial themes and prepare more targeted voir dire in cases involving complex medical evidence. The tool combines human verification with a Virtual Mirror Jury simulation and is positioned as decision support for licensed attorneys.

Why it matters: - Healthcare cases often turn on standards of care, expert testimony and technical medical evidence that can be hard for jurors to process. - ExposeIQ is pitching JuryFit as a way for trial teams to better anticipate juror reactions before selection and deliberation. - The platform is intended to support, not replace, attorney judgment in high-stakes litigation.

What happened: - ExposeIQ introduced JuryFit as part of its LENS trial intelligence suite for healthcare litigation attorneys. - The company says JuryFit analyzes case narratives against 16 juror personality profiles. - Human verification is built into the workflow at every step, from identifying likely juror personality blends to qualifying voir dire questions. - The platform includes a Virtual Mirror Jury™ feature that simulates seated jurors’ profiles in a virtual deliberation setting.

The details: - JuryFit is designed to help trial teams test arguments tied to standards of care, causation and damages. - The tool maps how different personality profiles may respond to medical terminology, expert credibility and negligence questions. - ExposeIQ says the system helps develop targeted voir dire strategies for the demands of healthcare cases. - The company says all platform outputs are decision-support resources and require independent review by licensed attorneys. - ExposeIQ says results vary by matter. - Joseph Terp, co-founder and CEO of ExposeIQ, said the platform is meant to give attorneys clearer visibility into potential panel reactions while preserving professional judgment.

Between the lines: - The launch reflects growing demand for litigation tools that combine analytics with subject-matter review in specialized practice areas. - The emphasis on human verification suggests ExposeIQ is trying to differentiate JuryFit from fully automated jury-selection tools. - The product also signals that healthcare defense and plaintiff teams are looking for more structured ways to handle complex scientific evidence.

What's next: - ExposeIQ is likely to position JuryFit as part of broader trial preparation workflows inside its LENS suite. - Attorneys using the platform will still need to independently review its outputs before relying on them in court. - The company’s message centers on more informed jury selection and mirror-jury preparation for future healthcare cases.

The bottom line: - JuryFit is ExposeIQ’s bet that AI-assisted jury analysis, paired with human review, can make healthcare voir dire more strategic and less speculative.